Blood hormone level tests can potentially predict a woman s risk for developing postmenopausal breast cancer for up to 20 years, according to data from Nurses Health study to be presented at the 11th annual meeting of the American Association for Cancer Research.
Search
A new study published in The Lancet supports the use of radiation therapy to prevent recurrence after surgery to remove the prostate (radical prostatectomy).
The Oklahoma Legislature is scheduled to have a committee hearing this Wednesday to discuss using tobacco harm reduction strategies as a means to reduce the health damage from cigarettes.
An old wives tale makes a comeback: Cranberry juice
Although rare, Duchenne muscular dystrophy (DMD) is a devastating genetic disease that ultimately results in muscle degeneration and death. With no known cure, the approximately 1 in 3,600 boys affected by the disease are treated with steroid drugs and physical therapy in order to improve their quality of life.
Older patients who have suffered a heart attack often don t bother to take medication that could potentially save their lives, a new eyebrow-raising study has found.
Perhaps New York Times columnist Nicholas Kristof should stick to live-tweeting brothel raids and parachuting into war zones because when it comes to covering science, he s way out of his depth.
We recently reported on a study published in BMJ finding that procedures involving radiation to the chest, including chest X-rays or mammograms, may significantly increase the already high risk of breast cancer that women with certain genetic mutations (BRCA1 or BRCA2) face.
Earlier this month we told you about an interesting dilemma faced by cities implementing bike sharing programs whether or not they should require users to wear helmets, which may increase biker safety at the cost of decreasing ridership. Piet de Jong, a professor of applied finance and actuarial studies at Macquarie University in Sydney, argues that pushing helmets really kills cycling and bike-sharing in particular because it promotes a sense of danger that just isn t justified.
Starving yourself overnight before having your blood taken for a cholesterol test may not be necessary after all. A new study finds there s only a slight difference between fasting and nonfasting cholesterol levels. There was some fluctuation with diet for triglyceride levels and blood sugar, however, but even that was slight.
The U.S. Preventive Services Task Force is recommending that all Americans aged 15 to 64 get tested for HIV at least once, regardless of their risk status. This sentiment has been echoed by the Centers for Disease Control and Prevention, especially since CDC data suggests that fewer than half of adults under 65 have been tested.
Women should be able to get birth control pills without a prescription, the American College of Obstetricians and Gynecologists recommended last week. Over-the-counter birth control availability has the potential to reduce unintended pregnancies which make up half of all pregnancies in the United States because lack of access to the pill is one of the main reasons that women fail to use contraception.
A new report presented at a meeting of acute cardiac care experts, but not yet published in a journal reveals that among 5,000 new admissions for heart attack, women died more than twice as often as men while in the hospital.
Warning: Your risk of dying is 100 percent. And if you live long enough, your chances of getting cardiovascular disease are rather high.
For diabetes patients with blockages in the coronary arteries, bypass surgery is better than angioplasty, according to the findings of a major new study that could change clinical practice.
If you have high blood pressure, watch out. You may be putting your brain at risk even if you re under 40.
In a quick note to all our readers and friends, today as you all know is Election Day, and ACSH will be monitoring the vote and hoping when Californians vote on Proposition 37, they ll vote in favor of sound science.
We ll look forward to reporting on this issue tomorrow.
In more promising news from the American Heart Association s Scientific Sessions in California, researchers have reported a key advance in using stem cells to repair damaged hearts.
University of California at Los Angeles chancellor Gene Block yesterday announced that the campus will go tobacco-free on April 22, 2013, which is Earth Day.
Researchers investigating breast cancer are reassessing the effects that alcohol can have on the disease, as ACSH s Dr. Gilbert Ross explains in his latest column for Examiner.com.
Teen pregnancy is a hot topic in the media and pop culture these days, as attested to by movies including "Juno" to "Teen Mom 2" to "16 and Pregnant." Events of recent weeks may indicate this concern is finally cracking the shell around our public health leaders as well better late than never.
Is the goal of eradicating breast cancer by 2020 unrealistic and overly ambitious? We were inclined to agree with a Nature editorial that said so, but one of our readers says no. Dr.
For most women who have been treated for breast cancer, taking tamoxifen (an estrogen blocker in breast tissue) can cut their odds of recurrence but for how long to take the drug to maximize benefit, has not been clear. Now a new study shows 10 years of tamoxifen treatment is better than five, lowering the risk of recurrence by a quarter and the risk of dying by 29 percent.
Yesterday, ACSH s Dr. Gilbert Ross presented ACSH s position on access to reduced-risk tobacco and nicotine products at the FDA s public meeting on nicotine replacement therapies and smoking-cessation products.
In his synopsis of the current sad state of affairs, Dr. Ross after discussing the counterproductive FDA approach to communicating risks called to account the public health authorities who have misled and continue to mislead smokers about the risks of various tobacco products. He states,
ACSH friend Jon Entine has written an incisive investigative piece featured in Slate.com exposing just how much politics can interfere with science. His chosen topic is the bizarre course towards eventual (we hope) governmental approval of the genetically-engineered AquaBounty salmon over the past two-plus years.
Pagination
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!